AHA 2013 schedule: Difference between revisions
Jump to navigation
Jump to search
Emily Larkin (talk | contribs) |
|||
| (16 intermediate revisions by 2 users not shown) | |||
| Line 23: | Line 23: | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===8: | ===8:45 AM=== | ||
''8:45 AM - 9:15 AM'' | |||
*'''Interview:''' Dr. Niklas Nielsen | |||
*'''Topic:''' Target Temperature Management 33°C versus 36°C after Out-of-hospital Cardiac Arrest, a Randomized, Parallel Group, Assessor Blinded Clinical Trial | |||
*'''Embargo lift:''' Sunday, November 17, 2013 at 4:00 PM | |||
===9:30 AM=== | ===9:30 AM=== | ||
| Line 38: | Line 38: | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===11: | ===11:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===11:45 AM=== | ===11:45 AM=== | ||
| Line 64: | Line 61: | ||
*'''Topic:''' Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve? | *'''Topic:''' Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve? | ||
*'''Embargo lift:''' Monday, November 18, 2013 at 10:45 AM | *'''Embargo lift:''' Monday, November 18, 2013 at 10:45 AM | ||
===2:30 PM=== | |||
''2:30 PM - 3:00 PM'' | |||
*'''Interview:''' Dr. Pierluigi Tricoci | |||
*'''Topic:''' Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study | |||
*'''Embargo lift:''' Sunday, November 19, 2013 at 9:00 AM | |||
===3:00 PM=== | ===3:00 PM=== | ||
''3:00 PM - 3:30 PM'' | ''3:00 PM - 3:30 PM'' | ||
*'''Interview:''' Farzin Fakhry | *'''Interview:''' Dr. Farzin Fakhry | ||
*'''Topic:''' Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients With Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised Exercise (ERASE) Trial | *'''Topic:''' Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients With Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised Exercise (ERASE) Trial | ||
*'''Embargo lift:''' Monday, November 18, 2013 at 3:45 PM | *'''Embargo lift:''' Monday, November 18, 2013 at 3:45 PM | ||
===3:30 PM=== | ===3:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
| Line 101: | Line 104: | ||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM – 9:30 AM'' | |||
*'''Interviewee: '''Dr. Francis Kim | |||
*'''Topic:''' Randomized Clinical Trial of Pre-hospital Induction of Mild Hypothermia in Out-of-Hospital Cardiac Arrest Patients Using a Rapid Infusion of 4oC Normal Saline | |||
*'''Embargo Lift:''' Sunday, November 17, 2013 at 4:00 PM | |||
===9:30 AM=== | ===9:30 AM=== | ||
| Line 113: | Line 119: | ||
*'''Interviewee:''' Dr. Stephen Nicholls | *'''Interviewee:''' Dr. Stephen Nicholls | ||
*'''Topic:''' Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results of the VISTA-16 Study | *'''Topic:''' Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results of the VISTA-16 Study | ||
*'''Embargo lift:''' Monday, November 18, 2013 at | *'''Embargo lift:''' Monday, November 18, 2013 at 3:45 PM | ||
===11:00 AM=== | ===11:00 AM=== | ||
| Line 139: | Line 145: | ||
*'''Interviewee:''' Dr. Nicole Li | *'''Interviewee:''' Dr. Nicole Li | ||
*'''Topic:''' China Rural Health Initiative - Sodium Reduction Study: the Effects of a Community-Based Sodium Reduction Program on 24hr Urinary Sodium and Blood Pressure in Rural China | *'''Topic:''' China Rural Health Initiative - Sodium Reduction Study: the Effects of a Community-Based Sodium Reduction Program on 24hr Urinary Sodium and Blood Pressure in Rural China | ||
*'''Embargo lift:''' Monday, November 18, 2013 at | *'''Embargo lift:''' Monday, November 18, 2013 at 9:00 AM | ||
===3:00 PM=== | ===3:00 PM=== | ||
*'''Interviewee:''' Dr. Marc Pfeffer | |||
*'''Topic:''' Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) | |||
*'''Embargo lift:''' Monday, November 18, 2013 at 10:45 AM | |||
===3:30 PM=== | ===3:30 PM=== | ||
| Line 163: | Line 171: | ||
''8:30 AM – 9:00 AM'' | ''8:30 AM – 9:00 AM'' | ||
*'''Interviewee:''' Dr. Christopher Cooper | *'''Interviewee:''' Dr. Christopher Cooper | ||
*'''Topic:''' A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL | *'''Topic:''' A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL Study | ||
*'''Embargo lift:''' Monday, November 18, 2013 at | *'''Embargo lift:''' Monday, November 18, 2013 at 3:45 PM | ||
===9:00 AM=== | ===9:00 AM=== | ||
| Line 195: | Line 203: | ||
''2:00 PM – 2:30 PM'' | ''2:00 PM – 2:30 PM'' | ||
*'''Interviewee:''' Dr. Hisao Ogawa | *'''Interviewee:''' Dr. Hisao Ogawa | ||
*'''Topic:''' TCT Wrap-Up in | *'''Topic:''' TCT Wrap-Up in Japanese | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM – 3:00 PM'' | |||
*'''Interviewee:''' Dr. Philip Aylward | |||
*'''Topic:''' TCT Wrap-Up from a Pacific Rim perspective | |||
===3:00 PM=== | ===3:00 PM=== | ||
''3:00 PM – 3:30 PM'' | |||
*'''Interviewee:''' Dr. Kristina Hambraeus | |||
*'''Topic:''' TCT Wrap-Up from a Scandinavian perspective | |||
===3:30 PM=== | ===3:30 PM=== | ||
| Line 220: | Line 232: | ||
*'''Interviewee:''' Dr. Munir Pirmohamed | *'''Interviewee:''' Dr. Munir Pirmohamed | ||
*'''Topic:''' A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study | *'''Topic:''' A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study | ||
*'''Embargo lift:''' Tuesday, November 19, 2013 at | *'''Embargo lift:''' Tuesday, November 19, 2013 at 10:45 AM | ||
===11:00 AM=== | ===11:00 AM=== | ||
| Line 226: | Line 238: | ||
*'''Interviewee:''' Dr. Robert Giugliano | *'''Interviewee:''' Dr. Robert Giugliano | ||
*'''Topic:''' ENGAGE AF-TIMI 48 Primary Results | *'''Topic:''' ENGAGE AF-TIMI 48 Primary Results | ||
*'''Embargo lift:''' Tuesday, November 19, 2013 at | *'''Embargo lift:''' Tuesday, November 19, 2013 at 10:45 AM | ||
Latest revision as of 18:40, 14 November 2013
Here is the page we will use to coordinate the TV events at AHA 2013. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Sunday, November 17, 2013
8:00 AM
OPEN TIME SLOT
8:45 AM
8:45 AM - 9:15 AM
- Interview: Dr. Niklas Nielsen
- Topic: Target Temperature Management 33°C versus 36°C after Out-of-hospital Cardiac Arrest, a Randomized, Parallel Group, Assessor Blinded Clinical Trial
- Embargo lift: Sunday, November 17, 2013 at 4:00 PM
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:45 AM
11:45 AM - 12:15 PM
- Interview: Dr. Horng Chen
- Topic: Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial
- Embargo lift: Monday, November 18, 2013 at 10:45 AM
1:00 PM
OPEN TIME SLOT
1:30 PM
1:30 PM - 2:00 PM
- Interview: Dr. Jaime Céspedes
- Topic: Promotion of Cardiovascular Health in Preschool Children: 36-month Cohort Follow-up
- Embargo lift: Monday, November 18, 2013 at 9:00 AM
2:00 PM
2:00 PM - 2:30 PM
- Interview: Dr. Michael Acker
- Topic: Severe Ischemic Mitral Regurgitation: Is it Better to Repair or Replace the Valve?
- Embargo lift: Monday, November 18, 2013 at 10:45 AM
2:30 PM
2:30 PM - 3:00 PM
- Interview: Dr. Pierluigi Tricoci
- Topic: Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study
- Embargo lift: Sunday, November 19, 2013 at 9:00 AM
3:00 PM
3:00 PM - 3:30 PM
- Interview: Dr. Farzin Fakhry
- Topic: Randomized Comparison of Endovascular Revascularization Plus Supervised Exercise Therapy Versus Supervised Exercise Therapy Only in Patients With Peripheral Artery Disease and Intermittent Claudication: Results of the Endovascular Revascularization and Supervised Exercise (ERASE) Trial
- Embargo lift: Monday, November 18, 2013 at 3:45 PM
3:30 PM
OPEN TIME SLOT
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Stephen Kimmel
- Topic: The Clarification of Optimal Anticoagulation through Genetics (COAG) Trial
- Embargo lift: Tuesday, November 19, 2013 at 10:45 AM
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Dr. Michael Ho
- Topic: Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge
- Embargo lift: Monday, November 18, 2013 at 9:00 AM
5:15 PM
5:15 PM - 5:45 PM
- Interviewee: Dr. Eric Ding
- Topic: Randomized Trial of Social Network Lifestyle Intervention for Obesity: MICROCLINIC Intervention Results and 16-Month Followup
- Embargo lift: Monday, November 18, 2013 at 9:00 AM
Monday, November 18, 2013
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM – 9:30 AM
- Interviewee: Dr. Francis Kim
- Topic: Randomized Clinical Trial of Pre-hospital Induction of Mild Hypothermia in Out-of-Hospital Cardiac Arrest Patients Using a Rapid Infusion of 4oC Normal Saline
- Embargo Lift: Sunday, November 17, 2013 at 4:00 PM
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Stephen Nicholls
- Topic: Secretory Phospholipase A2 Inhibition with Varespladib and Cardiovascular Events in Patients with an Acute Coronary Syndrome: Results of the VISTA-16 Study
- Embargo lift: Monday, November 18, 2013 at 3:45 PM
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Peter Sinnaeve
- Topic: One Year Mortality in STEMI Patients Randomized to Primary PCI or a Pharmaco-invasive Strategy. The Stream 1 Year Follow-up
- Embargo lift: Monday, November 18, 2013 at 3:45 PM
11:30 AM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Basil Lewis
- Topic: TCT Wrap-Up in Hebrew
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Nicole Li
- Topic: China Rural Health Initiative - Sodium Reduction Study: the Effects of a Community-Based Sodium Reduction Program on 24hr Urinary Sodium and Blood Pressure in Rural China
- Embargo lift: Monday, November 18, 2013 at 9:00 AM
3:00 PM
- Interviewee: Dr. Marc Pfeffer
- Topic: Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT)
- Embargo lift: Monday, November 18, 2013 at 10:45 AM
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Renato Lopes
- Topic: TCT Wrap-Up in Portuguese
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Tuesday, November 19, 2013
8:00 AM
OPEN TIME SLOT
8:30 AM
8:30 AM – 9:00 AM
- Interviewee: Dr. Christopher Cooper
- Topic: A Randomized Multicenter Clinical Trial of Renal Artery Stenting in Preventing Cardiovascular and Renal Events: Results of the CORAL Study
- Embargo lift: Monday, November 18, 2013 at 3:45 PM
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Freek W.A. Verheugt
- Topic: TCT Wrap-Up in Dutch
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
2:00 PM – 2:30 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: TCT Wrap-Up in Japanese
2:30 PM
2:30 PM – 3:00 PM
- Interviewee: Dr. Philip Aylward
- Topic: TCT Wrap-Up from a Pacific Rim perspective
3:00 PM
3:00 PM – 3:30 PM
- Interviewee: Dr. Kristina Hambraeus
- Topic: TCT Wrap-Up from a Scandinavian perspective
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
4:30 PM – 5:00 PM
- Interviewee: Dr. Juan Gaspar
- Topic: TCT Wrap-Up in Spanish
Wednesday, November 20, 2013
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Munir Pirmohamed
- Topic: A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study
- Embargo lift: Tuesday, November 19, 2013 at 10:45 AM
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Robert Giugliano
- Topic: ENGAGE AF-TIMI 48 Primary Results
- Embargo lift: Tuesday, November 19, 2013 at 10:45 AM